Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy

Neurology

Volumn 52, Issue 3, 1999, Pages 498-503

  Bouchard, C ^b   Lacroix, C ^b   Plante V ^b   Adams, D ^b   Chedru, F ^b   Guglielmi, J M ^b   Said, Gérard ^a  

^a BICÊTRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NERVE BIOPSY; POLYNEUROPATHY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032977603     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.3.498     Document Type: Article

References (27)

1. Targowla J. Polynévrite récidivante, envahissement des nerfs crâniens et diplégie faciale. Rev Neurol 1894;2:465-472.
2. Austin JH. Recurrent polyneuropathies and their corticosteroid treatment. Brain 1958;81:156-193.
3. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology 1991;41:617-618.
4. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-888.
5. Hughes RAC, Sanders E, Hall S, Atkinson P, Colchester A, Payan P. Subacute idiopathic demyelinating polyradiculoneuropathy. Arch Neurol 1992;49:612-616.
6. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997;48:321-328.
7. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okasaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clinic Proc 1975;50:621-637.
8. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 1987;110:1617-1630.
9. Pollard JD. Chronic inflammatory demyelinating polyradiculoneuropathy. In: McLeod J, ed. Inflammatory neuropathies. Baillière's clinical neurology. London: WB Saunders, 1994;3: 107-127.
10. Notermans NC, Wokke JHJ, Franssen H, et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993;56:1066-1071.
11. Maisonobe T, Chassande B, Verin M, Jouni M, Léger JM, Bouche P. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J Neurol Neurosurg Psychiatry 1996;61:36-42.
12. Simmons Z, Albers JW, Bromberg M, Feldman EL. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 1995;48:359-368.
13. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994;117:941-947.
14. Thomas PK, Walker RW, Rudge P, et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain 1987;110:53-76.
15. Mills KR, Murray NM. Neurophysiological evaluation of associated demyelinating peripheral neuropathy and multiple sclerosis: a case report. J Neurol Neurosurg Psychiatry 1986; 49:320-323.
16. Di Trapani G, Carnevale A, Cioffi RP, Massaro AR, Profice P. Multiple sclerosis associated with peripheral demyelinating neuropathy. Clin Neuropathol 1996;15:135-138.
17. Thomas PK, Lascelles RG, Hallpike JF, Hewer RL. Recurrent and chronic relapsing Guillain-Barré polyneuritis. Brain 1969;92:589-606.
18. Hinmann R, Magee KR. Guillain-Barré syndrome with slow progressive onset and persistent elevation of spinal fluid protein. Ann Intern Med 1967;67:1007-1112.
19. Said G, Guglielmi JM, Planté V, Ropert A, Hostachy T. Clinicopathological correlations in patients with unexcitable sensory nerves by the near nerve needle electrode method. J Neurol 1997;244(suppl 3):28. Abstract.
20. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine 1969;48:173-215.
21. Eisen A, Humphreys P. The Guillain-Barré syndrome: a clinical and electrodiagnostic study of 25 cases. Arch Neurol 1974; 30:438-443.
22. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996;39: 17-28.
23. Berciano J, Figols J, García A, et al. Fulminant Guillain-Barré syndrome with universal inexcitability of peripheral nerves: a clinicopathological study. Muscle Nerve 1997;20: 846-857.
24. Dyck PJ, Karnes JL, Lambert EH. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 1989; 39:1302-1308.
25. Madrid RE, Wisniewski HM. Axonal degeneration in demyelinating disorders. J Neurocytol 1977;6:103-117.
26. Said G, Saida K, Saida T, Asbury AK. Axonal lesions in acute experimental demyelination: a sequential teased nerve fiber study. Neurology 1981;31:413-421.
27. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.